Intensive Smoking Cessation Intervention Reduces Mortality in High-Risk Smokers With Cardiovascular Disease
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Purposes To compare an intensive smoking cessation intervention against usual care in hospitalized high-risk smokers with acute cardiovascular disease.Methods A total of 209 hospitalized smokers were randomized to the intensive intervention (n = 109) or to usual care (n = 100). Usual care consisted only of counseling and printed educational material provided prior to hospital discharge. Intensive treatment consisted of a minimum of 12 weeks of behavior modification counseling and individualized pharmacotherapy provided at no cost to the participant. Smoking status in all subjects was confirmed biochemically (ie, by measuring expired carbon monoxide) at 3, 6, 12, and 24 months after randomization. Outcomes included point prevalence and continuous abstinence smoking cessation rates, hospitalizations, and all-cause mortality.Results At each follow-up interval, point prevalence and continuous abstinence smoking cessation rates were significantly greater in the intensive-treatment group compared to the usual-care group. At 24 months, continuous abstinence smoking cessation rates were 33% in the intensive-treatment group and 9% in the usual-care group (p < 0.0001). Over the 2-year follow-up period, 41 patients in the usual-care group were hospitalized compared to 25 patients in the intensive-treatment group (relative risk reduction [RRR], 44%; 95% confidence interval [CI], 16 to 63%; p = 0.007). The all-cause mortality rate was 2.8% in the intensive-treatment group and 12.0% in the usual-care group (RRR, 77%; 95% CI, 27 to 93%; p = 0.014). The absolute risk reduction in mortality was 9.2% with a number needed to treat of 11.Conclusion Hospitalized smokers, especially those with cardiovascular disease, should undergo treatment with a structured intensive cessation intervention. The duration of the initial treatment should be 3 months.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, evidence from randomized trials supports the beneficial effect of smoking cessation.251,252”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [252]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Fagerström, K.-O. (1978) · Addictive Behaviors · doi:10.1016/0306-4603(78)90024-2 · Cited by 2,221
Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174516 · Cited by 2,104
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.002 · Cited by 1,020
Income inequality and population health
Mackenbach, J. P. (2002) · BMJ · doi:10.1136/bmj.324.7328.1 · Cited by 845
Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.026 · Cited by 671
Smoking Cessation after Acute Myocardial Infarction: Effects of a Nurse-Managed Intervention
Taylor, C. B., Houston-Miller, N., Killen, J. D., & DeBusk, R. F. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-2-118 · Cited by 394
Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction
Rea, T. D., Heckbert, S. R., Kaplan, R. C., Smith, N. L., Lemaitre, R. N., & Psaty, B. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00009 · Cited by 213
Smoking cessation and severity of disease: The Coronary Artery Smoking Intervention Study.
Ockene, J., Kristeller, J. L., Goldberg, R., & Ockene, I. (1992) · Health Psychology · doi:10.1037//0278-6133.11.2.119 · Cited by 209
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
Gaziano, T. A., Bitton, A., Anand, S., Abrahams-Gessel, S., & Murphy, A. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2009.10.002 · Cited by 1,176
Achievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1213829 · Cited by 979
Rooke, T. W., Hirsch, A. T., Misra, S., Sidawy, A. N., Beckman, J. A., Findeiss, L. K., Golzarian, J., Gornik, H. L., Halperin, J. L., Jaff, M. R., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.023 · Cited by 924
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Interventions for smoking cessation in hospitalised patients
Rigotti, N. A., Clair, C., Munafò, M. R., & Stead, L. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001837.pub3 · Cited by 751
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 691
Psychological interventions for coronary heart disease.
Richards, S. H., Anderson, L., Jenkinson, C. E., Whalley, B., Rees, K., Davies, P., Bennett, P., Liu, Z., West, R., Thompson, D. R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002902.pub4 · Cited by 571
Rooke, T. W., Hirsch, A. T., Misra, S., Sidawy, A. N., Beckman, J. A., Findeiss, L. K., Golzarian, J., Gornik, H. L., Halperin, J. L., Jaff, M. R., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31822e80c3 · Cited by 334
Cardiac rehabilitation past, present and future: an overview.
Mampuya, W. M. (2012) · PubMed · doi:10.3978/j.issn.2223-3652.2012.01.02 · Cited by 314
“javascript:showrefcontent(‘refrencesla yer’); The overall mortality risk of smokers who quit decreases by 50% in the first couple of years and tends to approach that of nonsmokers in approximately 5-15 years of cessation of smoking (38).”
BackgroundPerk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 311
“Also, evidence from randomized trials supports the beneficial effect of smoking cessation.(251,252) Further evidence points towards risk of CVD approaching the risk of never-smokers within 10–15 years, without ever quite reaching the same level.”
Cigarette smoking: An undertreated risk factor for cardiovascular disease
Erhardt, L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.007 · Cited by 286
Smoking Cessation Interventions for Hospitalized Smokers: A Systematic Review
Rigotti, N. A., Munafo, M. R., & Stead, L. F. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.1950 · Cited by 273
“tified 1 additional article through the current contents alerting service.(6)”
BackgroundInfluentialCombined pharmacotherapy and behavioural interventions for smoking cessation
Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008286.pub3 · Cited by 829
Leone, F. T., Zhang, Y., Evers-Casey, S., Evins, A. E., Eakin, M. N., Fathi, J., Fennig, K., Folan, P., Galiatsatos, P., Gogineni, H., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1982st · Cited by 249
“For example, should patients with COPD who continue to smoke receive longer-duration treatment, given their recognized dependence severity (147)? Would patients with a history of depression or alcoholism benefit from combination pretreatment with bupropion (148, 149)? Does the pharmacotherapy follow-up interval after…”
2018 Guidelines for the management of dyslipidemia
Rhee, E.-J., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, H. J., Choi, S., et al. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.188 · Cited by 213
Lundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., et al. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00534.x · Cited by 210
Rooke, T. W., Hirsch, A. T., Misra, S., Sidawy, A. N., Beckman, J. A., Findeiss, L. K., Golzarian, J., Gornik, H. L., Halperin, J. L., Jaff, M. R., et al. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.09.001 · Cited by 211
Combined pharmacotherapy and behavioural interventions for smoking cessation
Stead, L. F., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008286.pub2 · Cited by 204
Williams, G. C., Niemiec, C. P., Patrick, H., Ryan, R. M., & Deci, E. L. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9090-y · Cited by 201
“Smokers who quit live longer than those who continue to smoke (3) and those who receive intensive treatment receive a mortality benefit (4,5).”
2018 Guidelines for the Management of Dyslipidemia in Korea
Rhee, E.-J., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, H. J., Choi, S., et al. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.78 · Cited by 192
Interventions for smoking cessation in hospitalised patients
Rigotti, N., Munafo', M. R., & Stead, L. F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001837.pub2 · Cited by 187
Psychological interventions for coronary heart disease
Whalley, B., Rees, K., Davies, P., Bennett, P., Ebrahim, S., Liu, Z., West, R., Moxham, T., Thompson, D. R., & Taylor, R. S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002902.pub3 · Cited by 194
A Cascade of Care for Diabetes in the United States: Visualizing the Gaps
Ali, M. K., Bullard, K. M., Gregg, E. W., & del Rio, C. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0019 · Cited by 182
Managing tobacco use: the neglected cardiovascular disease risk factor
Rigotti, N. A., & Clair, C. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht352 · Cited by 182
Kabboul, N. N., Tomlinson, G., Francis, T. A., Grace, S. L., Chaves, G., Rac, V., Daou-Kabboul, T., Bielecki, J. M., Alter, D. A., & Krahn, M. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120514 · Cited by 180
Diretrizes para cessação do tabagismo - 2008
Reichert, J., Araújo, A. J. D., Gonçalves, C. M. C., Godoy, I., Chatkin, J. M., Sales, M. D. P. U., & Santos, S. R. R. D. A. (2008) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132008001000014 · Cited by 166
Effect of smoking cessation on the risk of dementia: a longitudinal study
Choi, D., Choi, S., & Park, S. M. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.633 · Cited by 134
French Society of Cardiology guidelines for cardiac rehabilitation in adults
Pavy, B., Iliou, M., Vergès-Patois, B., Brion, R., Monpère, C., Carré, F., Aeberhard, P., Argouach, C., Borgne, A., Consoli, S. M., et al. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2012.01.010 · Cited by 135
“[56] Mohiuddin SM, Mooss AN, Hunter CB, et al.”
BackgroundMullen, K. A., Manuel, D. G., Hawken, S., Pipe, A., Coyle, D., Hobler, L. A., Younger, J., Wells, G. A., & Reid, R. D. (2016) · Tobacco Control · doi:10.1136/tobaccocontrol-2015-052728 · Cited by 126
“Extrapolation of our results to other settings should consider these limitations.”
ResultKivimäki, M., Nyberg, S. T., Fransson, E. I., Heikkilä, K., Alfredsson, L., Casini, A., Clays, E., De Bacquer, D., Dragano, N., Ferrie, J. E., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121735 · Cited by 113
“31,32 Evidence for the beneficial effects of physical activity 33,34 and the adverse effects of high alcohol consumption 25,35,36 and job strain 7,37 on heart disease is mostly limited to observational studies.”
Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Shivashankar, R., Ajay, V. S., Unnikrishnan, A. G., Menon, V. U., Varthakavi, P. K., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2807 · Cited by 109
“Diabetes management focuses on reducing patients' risk for microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (coronary, cerebrovascular, and peripheral vascular diseases) complications through control of blood glucose levels (2–5), blood pressure (BP) (6–8), and lipid levels (9, 10) and avoida…”
BackgroundSuissa, K., Larivière, J., Eisenberg, M. J., Eberg, M., Gore, G. C., Grad, R., Joseph, L., Reynier, P. M., & Filion, K. B. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002458 · Cited by 109
Global Burden of Cardiovascular Disease
Gaziano, T. A., & Gaziano, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00001-9 · Cited by 120
Williams, G. C., Patrick, H., Niemiec, C. P., Ryan, R. M., Deci, E. L., & Lavigne, H. M. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.03.002 · Cited by 100
Sharpe, T., Alsahlanee, A., Ward, K. D., & Doyle, F. (2018) · The Journal of Smoking Cessation · doi:10.1017/jsc.2017.25 · Cited by 93
“…by various publications as a substantial factor to poor provision of smoking cessation interventions and so, it is unsurprising that it was reported in the papers reviewed (Cabana et al., 1999; McLeod, Somasundaram, Howden-Chapman, & Dowell, 2000; Mohiuddin et al., 2007; Sarna et al., 2009).”
BackgroundResult2011 WRITING GROUP MEMBERS*, Rooke, T. W., Hirsch, A. T., Misra, S., Sidawy, A. N., Beckman, J. A., Findeiss, L., Golzarian, J., Gornik, H. L., Halperin, J. L., et al. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23373 · Cited by 98
Rooke, T. W., Hirsch, A. T., Misra, S., Sidawy, A. N., Beckman, J. A., Findeiss, L., Golzarian, J., Gornik, H. L., Halperin, J. L., Jaff, M. R., et al. (2011) · Vascular Medicine · doi:10.1177/1358863x11424312 · Cited by 95
Smoking cessation: health system challenges and opportunities
Pipe, A., Evans, W. K., & Papadakis, S. (2022) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056575 · Cited by 101
Meisner, A., Kundu, P., Zhang, Y. D., Lan, L. V., Kim, S., Ghandwani, D., Pal Choudhury, P., Berndt, S. I., Freedman, N. D., Garcia-Closas, M., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.07.002 · Cited by 79
Lifestyle Modification in Secondary Prevention: Beyond Pharmacotherapy
Brinks, J., Fowler, A., Franklin, B. A., & Dulai, J. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827616651402 · Cited by 100
“In a study that combined intensive smoking cessation counseling with pharmacotherapy in hospitalized acute-MI patients, quit rates, all-cause mortality, and hospital readmissions were all positively affected as compared with a usual care group.(61) In another systematic review, Rigotti et al(62) found that smoking ces…”
ResultSimplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.
Allan, G. M., Lindblad, A. J., Comeau, A., Coppola, J., Hudson, B., Mannarino, M., McMinis, C., Padwal, R. S., Schelstraete, C., Zarnke, K. B., et al. (2015) · Europe PMC (PubMed Central) · Cited by 72
Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
Planer, D., Lev, I., Elitzur, Y., Sharon, N., Ouzan, E., Pugatsch, T., Chasid, M., Rom, M., & Lotan, C. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.72 · Cited by 70
“It has also been recognized that the hospitalization period is an important opportunity to intervene in this high-risk population.(16,17) However, even in recently published studies, patients with unstable angina and MI were excluded from smoking cessation trials due to unproven safety of bupropion in these patients.”
BackgroundKnowledge gaps about smoking cessation in hospitalized patients and their doctors
Raupach, T., Merker, J., Hasenfuss, G. P., Andreas, S., & Pipe, A. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389370 · Cited by 76
“Such interventions can dramatically reduce rates of readmission and all-cause mortality.(6) Very few studies have assessed the extent to which hospitalized patients are being screened for their smoking status and, when appropriate, being provided with adequate cessation advice and support.”
BackgroundCardio Metabolic Syndrome: A Global Epidemic
Kelli, H. M., & Kassas, I. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000513 · Cited by 95
“Alcohol consumption had inverse relations with insulin levels, TG levels and low HDL as well as central obesity [144].”
BackgroundSystematic review and meta-analysis of combination therapy for smoking cessation
shah, S. D., Wilken, L. A., Winkler, S., & Lin, S. (2008) · Journal of the American Pharmacists Association · doi:10.1331/japha.2008.07063 · Cited by 77
Doyle, F., Rohde, D., Rutkowska, A., Morgan, K., Cousins, G., & McGee, H. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000020 · Cited by 68
“Although cessation counseling with more than 1-month follow-up has been shown to be effective for cardiac patients (1) and can even reduce postdischarge mortality when combined with pharmacotherapy (60), no randomized trials have assessed smoking interventions in depressed cardiac patients specifically.”
Ali, M. K., Shah, S., & Tandon, N. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500310 · Cited by 67
“Study designs represented in this review included RCTs (9), cluster RCTs (4), quasiexperimental studies (8), retrospective (audit, chart review) comparisons (4), and a single cohort study.”
MethodRespiratory, cardiovascular and other physiological consequences of smoking cessation
Gratziou, C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802707642 · Cited by 69
Clinical and public health significance of treatments to aid smoking cessation
West, R., & Stapleton, J. (2008) · European Respiratory Review · doi:10.1183/09059180.00011005 · Cited by 60
“Another randomised trial found that in smokers who had had a myocardial infarction, those who had received intensive cessation treatment had lower mortality at follow-up than those receiving brief advice [ 13 ].”
BackgroundEffectiveness of nonpharmacological secondary prevention of coronary heart disease
Müller-Riemenschneider, F., Meinhard, C., Damm, K., Vauth, C., Bockelbrink, A., Greiner, W., & Willich, S. N. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32833a1c95 · Cited by 57
A systematic review of possible serious adverse health effects of nicotine replacement therapy
Lee, P. N., & Fariss, M. W. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1856-y · Cited by 82
“…were generally few, only exceeding 10 in the case series analysis (Hubbard et al. 2005), the RRs were, with one exception, below 1.00, though only the RR of 0.23 (95 % CI 0.07–0.73) for the study of 1 3 intensive intervention versus usual care (Mohiuddin et al. 2007) was significant at p < 0.05.”
BackgroundMethodResultInfluentialReichert, V., Xue, X., Bartscherer, D., Jacobsen, D., Fardellone, C., Folan, P., Kohn, N., Talwar, A., & Metz, C. N. (2009) · Chest · doi:10.1378/chest.08-2288 · Cited by 55
Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients
Stein, J. H., Hadigan, C. M., Brown, T. T., CHADWICK, E. G., Feinberg, J., Friis‐Møller, N., Ganesan, A., Glesby, M. J., Hardy, D., Kaplan, R. C., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189628 · Cited by 59
Examining sustainability in a hospital setting: Case of smoking cessation
Campbell, S., Pieters, K., Mullen, K.-A., Reece, R., & Reid, R. D. (2011) · Implementation Science · doi:10.1186/1748-5908-6-108 · Cited by 51
Clark, B. J., & Moss, M. M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821858bb · Cited by 55
“In addition to increasing the rate of smoking cessation, intensive interventions may also decrease the rate of rehospitalization and improve mortality (50).”
BackgroundPaciullo, C. A., Short, M. R., Steinke, D. T., & Jennings, H. R. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l423 · Cited by 50
Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities
Godtfredsen, N. S., & Prescott, E. (2011) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2011.00262.x · Cited by 49
“Smoking more than doubles the risk of all types of CVD – CHD, ischemic stroke, peripheral arterial disease (PAD) and abdominal aortic aneurism (AAA) – and changing smoking behaviour is a cornerstone of improved CVD health.”
BackgroundInfluentialCartmell, K. B., Dooley, M. J., Mueller, M., Nahhas, G. J., Dismuke, C. E., Warren, G. W., Talbot, V., & Cummings, K. M. (2018) · Medical Care · doi:10.1097/mlr.0000000000000884 · Cited by 51
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 74
The Role of Smoking Cessation in the Prevention of Coronary Artery Disease
Pipe, A., Papadakis, S., & Reid, R. D. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0105-8 · Cited by 55
Chan, S. S. C., Leung, D. Y. P., Wong, D. C. N., Lau, C., Wong, V. T., & Lam, T. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03733.x · Cited by 43
Berndt, N. C., Bolman, C. A. W., Froelicher, E. S., Mudde, A. N., Candel, M. J. J. M., de Vries, H., & Lechner, L. (2013) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9522-9 · Cited by 50
“It significantly reduces the risk of mortality, re-hospitalization and reoccurrence after a coronary event (Critchley & Capewell, 2003; Mohiuddin et al., 2007; Van Spall et al., 2007).”
BackgroundSmoking Cessation and the Cardiovascular Specialist: Canadian Cardiovascular Society Position Paper
Pipe, A., Eisenberg, M. J., Gupta, A. K., Reid, R. D., Suskin, N., & Stone, J. A. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.060 · Cited by 48
Raupach, T., Falk, J., Vangeli, E., Schiekirka, S., Rustler, C., Grassi, M., Pipe, A., & West, R. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312462803 · Cited by 42
Bredie, S. J. H., Fouwels, A., Wollersheim, H. C. H., & Schippers, G. M. (2011) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2010.06.003 · Cited by 58
Gerritsen, M., Berndt, N. C., Lechner, L., de Vries, H., Mudde, A. N., & Bolman, C. A. W. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000137 · Cited by 45
“For patients with cardiac disease, smoking cessation is very desirable as it improves their prognosis more than any other treatment (Mohiuddin et al., 2007) and considerably decreases their risk of reoccurrence and of mortality (Critchley & Capewell, 2003).”
BackgroundManagement of metabolic complications and cardiovascular risk in HIV-infected patients.
Blanco, F., Román, J. S., Vispo, E., López, M., Salto, A., Abad, V., & Soriano, V. (2010) · PubMed · Cited by 48
Mullen, K., Coyle, D., Manuel, D. G., Nguyen, H. V., Pham, B., Pipe, A., & Reid, R. D. (2014) · Tobacco Control · doi:10.1136/tobaccocontrol-2013-051483 · Cited by 40
Interventions for smoking cessation in hospitalised patients
Streck, J. M., Rigotti, N. A., Livingstone‐Banks, J., Tindle, H. A., Clair, C., Munafo, M. R., Sterling-Maisel, C., & Hartmann‐Boyce, J. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001837.pub4 · Cited by 68
Berndt, N. C., Hayes, A. F., Verboon, P., Lechner, L., Bolman, C. A. W., & de Vries, H. (2013) · Psychology of Addictive Behaviors · doi:10.1037/a0028737 · Cited by 46
Smoking Cessation Treatment Practices: Recommendations for Improved Adoption on Cardiology Wards
Berndt, N. C., Bolman, C. A. W., de Vries, H., Segaar, D., Boven, I. V., & Lechner, L. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318231f424 · Cited by 42
Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation
Keating, G. M., & Lyseng-Williamson, K. A. (2010) · PharmacoEconomics · doi:10.2165/11204380-000000000-00000 · Cited by 39
“For example, in high-risk smokers hospitalized with acute cardiovascular disease, intensive treatment comprising counselling and individualized pharmacotherapy was not only associated with higher continuous abstinence rates than usual care comprising counselling and educational material, but was also associated with a…”
Steinberg, M. B., Randall, J., Greenhaus, S., Schmelzer, A. C., Richardson, D. L., & Carson, J. L. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.07.002 · Cited by 39
Busch, A. M., Tooley, E. M., DUNSIGER, S. I., Chattillion, E. A., Srour, J. F., Pagoto, S., Kahler, C. W., & Borrelli, B. (2017) · BMC Public Health · doi:10.1186/s12889-017-4250-7 · Cited by 38
“Adaptation was also guided by clear meta-analytic data on the dose of treatment needed for significant effects on smoking cessation in hospitalized cardiac patients [29, 30].”
Gowrisankaran, G., Norberg, K. E., Kymes, S. M., Chernew, M. E., Stwalley, D. L., Kemper, L. M., & Peck, W. A. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.0090 · Cited by 37
Patient Education Strategies for Hospitalized Cardiovascular Patients: A Systematic Review
Commodore-Mensah, Y. Y., & Himmelfarb, C. D. (2012) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318239f60f · Cited by 36
Hammal, F., Ezekowitz, J. A., Norris, C. M., Wild, T. C., Finegan, B. A., & Approach Investigators (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-133 · Cited by 34
“More intensive behavioral interventions with at least one month of supportive contacts after hospital discharge increased cessation rates [31,32], as does add pharmacological management [30,33].”
BackgroundStructured Smoking Cessation Training for Medical Students: A Prospective Study
Herold, R., Schiekirka-Schwake, S., Brown, J., Bobak, A., McEwen, A., & Raupach, T. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw191 · Cited by 40
Berndt, N., Bolman, C., Lechner, L., Mudde, A., Verheugt, F. W., & de Vries, H. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-33 · Cited by 31
“Smoking cessation after a first coronary event such as a myocardial infarction significantly reduces the risk of mortality, hospitalisation rates and reoccurrence [4-6].”
BackgroundMcCullough, P. A., & Verrill, T. A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.03.2119 · Cited by 38
Auer, R., Gencer, B., Tango, R. C., Nanchen, D., Matter, C. M., Lüscher, T. F., Windecker, S., Mach, F., Cornuz, J., Humair, J., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011520 · Cited by 30
Matcham, F., Carroll, A., Chung, N. A. Y., Crawford, V., Galloway, J. B., Hames, A., Jackson, K., Jacobson, C. E. H., Manawadu, D., McCracken, L. M., et al. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.11.006 · Cited by 32
Human Immunodeficiency Virus and Atherosclerosis
Farrugia, P. M., Lucariello, R. J., & Coppola, J. T. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181b151a3 · Cited by 28
“Previously, it has been shown that intensive smoking cessation intervention in smokers with cardiovascular disease is not only effective in achieving smoking cessation, but also in reducing hospitalizations and total mortality.(15) Clearly, smoking cessation efforts need to be increased given the staggering number of…”
BackgroundBakker, E. C., Nijkamp, M. D., Sloot, C., Berndt, N. C., & Bolman, C. A. W. (2014) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000156 · Cited by 31
“Smoking is not only an important cause of cardiac diseases; cardiac patients who continue smoking after hospital discharge also have a higher risk for another cardiac incident.(1,2) Quitting smoking after the development of coronary heart disease improves prognosis more than any other treatment and is associated with…”
BackgroundReeves, G. R., Wang, T. Y., Reid, K. J., Alexander, K. P., Decker, C., Ahmad, H., Spertus, J. A., & Peterson, E. D. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2111 · Cited by 25
“Intensive inpatient counseling, combined with outpatient follow-up, has been associated with improved cessation and mortality rates.(31,34,35) There may also be a disconnect between what actually occurs during SCC at the patient’s bedside and what is documented in the medical record.”
Berndt, N. C., Bolman, C. A. W., Mudde, A. N., Verheugt, F. W. A., de Vries, H., & Lechner, L. (2012) · Heart & Lung · doi:10.1016/j.hrtlng.2012.03.001 · Cited by 30
Effectiveness of the Tobacco Tactics Program in the Trinity Health System
Duffy, S. A., Ronis, D. L., Karvonen-Gutierrez, C. A., Ewing, L. A., Hall, S. V., Yang, J. J., Thomas, P. L., Olree, C. M., Maguire, K. A., Friedman, L., et al. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.03.012 · Cited by 25
Cambra, K., Galbete, A., Forga, L., Lecea, Ó., Ariz, M. J., Moreno-Iribas, C., Aizpuru, F., & Ibáñez, B. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0533-9 · Cited by 25
“and LDL-cholesterol levels and avoiding tobacco consumption [3–8].”
BackgroundHuttunen‐Lenz, M., Song, F., & Poland, F. M. (2010) · British Journal of Health Psychology · doi:10.1348/135910709x480436 · Cited by 25
Japuntich, S. J., Regan, S., Viana, J. C., Tymoszczuk, J., Reyen, M., Levy, D. E., Singer, D. E., Park, E. R., Chang, Y., & Rigotti, N. A. (2012) · Trials · doi:10.1186/1745-6215-13-124 · Cited by 27
“Subsequent trials support this conclusion [9-11].”
Vascular protection in peripheral artery disease: systematic review and modelling study
Hackam, D. G., Sultan, N. S., & Criqui, M. H. (2009) · Heart · doi:10.1136/hrt.2008.161554 · Cited by 25
Baliunas, D. O., Zawertailo, L. A., Voci, S. C., Gatov, E., Bondy, S. J., Fu, L., & Selby, P. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235709 · Cited by 23
Understanding and Promoting Effective Self-Care During Heart Failure
Clark, A. M., Davidson, P. M., Currie, K., Karimi-Dehkordi, M., Duncan, A. S., & Thompson, D. R. (2010) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0053-1 · Cited by 30
“Patients with HF should be referred to these interventions if they are appropriate and available [32,33] (class I). & Smoking cessation counseling may be provided while patients are hospitalized for HF [ 34 ] (class II).”
BackgroundEffect of an Educational Program (PEGASE) on Cardiovascular Risk in Hypercholesterolaemic Patients
Bruckert, É., Giral, P., Paillard, F., Ferrières, J., Schlienger, J.-L., Renucci, J.-F., ABDENNBI, K., Durack-Bown, I., Chadarévian, R., & PEGASE group (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6137-4 · Cited by 26
Comparison of two smoking cessation interventions for inpatients
Campos, A. C. F., Nani, Â. S. F., Fonseca, V. A. D. S., Silva, E. N., de Castro, M. C. S., & Martins, W. D. A. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000419 · Cited by 24
“Tobacco-related diseases constitute one of the main causes of hospital admission.(1-3) When smoking patients are hospitalized, it is recommended that they be given counseling and treatment for nicotine dependence, during hospitalization and for at least four weeks after discharge.”
Background
Metadata
- Authors
- Mohiuddin, S. M., Mooss, A. N., Hunter, C. B., Grollmes, T. L., Cloutier, D. A., & Hilleman, D. E.
- Affiliations
- Creighton University (US)
- Corresponding author
- Hilleman, Daniel E.
- ORCID
- Hilleman, Daniel E.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 131
- Issue
- 2
- Pages
- 446-452
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1994184771
- Cited by
- 281
- References
- 26
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 12 · 2021: 5 · 2020: 8 · 2019: 9 · 2018: 15 · 2017: 17 · 2016: 21 · 2015: 18 · 2014: 12 · 2013: 19 · 2012: 32
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- smoking cessation, intensive intervention, cardiovascular disease, hospitalized smokers, all-cause mortality, continuous abstinence, nicotine replacement therapy, hospital readmission, usual care
- MeSH terms
- Adult, Aged, Behavior Therapy, Cardiovascular Diseases, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Smoking Cessation, Bupropion, Treatment Outcome, Dopamine Uptake Inhibitors, Directive Counseling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.